Search results
FTC Chief Says Tech Advancements Risk Healthcare Price Fixing
MedPage Today· 5 days agoAlgorithms make it possible for companies to fix prices without explicitly coordinating with one...
Pioneer Natural Resources co-founder will be barred from board in deal for Exxon merger
Dallas Morning News· 3 days agoThe Federal Trade Commission is poised to greenlight Exxon Mobil’s $60 billion purchase of...
FTC plans to recommend a possible criminal case against ex-Pioneer CEO
Semafor via Yahoo Finance· 2 days agoAs part of its Exxon deal review, the US agency uncovered comments Scott Sheffield made to Texas...
UnitedHealth CEO faces Change Healthcare hack scrutiny on Capitol Hill
Market Watch· 3 days ago“This corporation is a healthcare leviathan,” Senate Finance Committee chair Sen. Ron Wyden, Democrat from Oregon, said at a hearing with UnitedHealth Chief Executive Andrew Witty Wednesday ...
FTC's noncompete ban could reshape the US workplace
Yahoo Finance via AOL· 6 days agoThe FTC’s decision to outlaw nearly all noncompete agreements could restructure the balance of power between businesses and workers — if it survives...
Amazon, Target among retailers to pull weighted infant sleepwear over safety concerns
FOX 10 Phoenix· 2 days agoAmazon, Target, and Walmart are among retailers that will no longer sell weighted sleepwear over...
Preparation key for ‘tectonic change’ from FTC noncompete ban
Compliance Week· 3 days agoCompanies would be wise to prepare to comply with the Federal Trade Commission’s (FTC) rule to ban...
US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition
Las Vegas Review-Journal· 4 days ago“By filing bogus patent listings, pharma companies block competition and inflate the cost of...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KSAN - KLST San Angelo· 4 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 4 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...